The extracellular domain of Her2 in serum as a biomarker of breast cancer.

Perrier A, Gligorov J, Lefèvre G, Boissan M

Open source

DOI
10.1038/s41374-018-0033-8
Published
2018 Jun
Container
Laboratory investigation; a journal of technical methods and pathology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41374-018-0033-8,
  title = {The extracellular domain of Her2 in serum as a biomarker of breast cancer.},
  author = {Perrier A and Gligorov J and Lefèvre G and Boissan M},
  year = {2018},
  journal = {Laboratory investigation; a journal of technical methods and pathology},
  doi = {10.1038/s41374-018-0033-8},
  url = {https://doi.org/10.1038/s41374-018-0033-8}
}

RIS

TY  - JOUR
TI  - The extracellular domain of Her2 in serum as a biomarker of breast cancer.
AU  - Perrier A
AU  - Gligorov J
AU  - Lefèvre G
AU  - Boissan M
PY  - 2018
JO  - Laboratory investigation; a journal of technical methods and pathology
DO  - 10.1038/s41374-018-0033-8
UR  - https://doi.org/10.1038/s41374-018-0033-8
ER  - 

APA

A, P., J, G., G, L., & M, B. (2018). The extracellular domain of Her2 in serum as a biomarker of breast cancer.. Laboratory investigation; a journal of technical methods and pathology. https://doi.org/10.1038/s41374-018-0033-8

Source records